Effect of standardized treatment strategy based on risk assessment of nausea and vomiting on postoperative nausea and vomiting in gynecological patients

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047571

Enrollment

Unknown

Registered

2021-06-20

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative nausea and vomiting

Interventions

Group 1:standard treatment

Group 2:traditional treatment

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Sign the informed consent; 2. Aged 18 to 65 years; 3. Patients undergoing laparoscopic gynecological surgery under elective general anesthesia; 4. ASA I or II grade.

Exclusion criteria

Exclusion criteria: 1. Emergency surgery patients; 2. Patients with gastrointestinal diseases; 3. Taking antiemetic drugs within 24 hours before surgery; 4. Those who are allergic to drugs.

Design outcomes

Primary

Measure	Time frame
incidence of nausea and vomiting;	—

Countries

China

Contacts

Public ContactYao Weidong

Yijishan Hospital of Wannan Medical College

docmwj@163.com+86 18214716938

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026